Dried botanicals and a glass beaker of petals arranged on a polished dark stone bench.
Beauty Science · Ingredient Library · Tier 1

Alpha-arbutin

A decorative microscopic-texture image showing a rosette of fine needle-like crystals.
Alpha-arbutinC12H16O7272.25 g/mol

What is alpha-arbutin?

Arbutin is hydroquinone with a glucose molecule attached. That glycosidic bond is the point: it makes the molecule stable and far less cytotoxic than free hydroquinone, while allowing slow release of a hydroquinone-like activity in skin. Alpha-arbutin is the alpha-anomer, which is more stable and more active than the beta form found in bearberry extract, and is produced biosynthetically.

How does alpha-arbutin work?

Competitive inhibition of tyrosinase, the rate-limiting enzyme converting tyrosine to melanin precursors. This is upstream interference in melanin synthesis, distinct from tranexamic acid's action on inflammatory signalling and from niacinamide's interference with melanosome transfer - which is why these three are frequently combined, as they are in Vegalab's Brightening line.

The hydroquinone question, handled honestly

Because arbutin can release hydroquinone, the obvious question is whether it carries hydroquinone's concerns. The glycoside is considerably better tolerated and is permitted in cosmetics in jurisdictions where hydroquinone is not, but the mechanism does mean the two are related rather than unrelated. Regulatory limits on arbutin concentration exist in several markets and vary - a page like this should not state a global limit.

What does alpha-arbutin not do?

It does not remove existing pigment, only slows new synthesis, so results take months and require sun protection. It is not a treatment for melasma on its own. And biosynthetic production makes it purer, not more natural in any meaningful sense.

References

  1. Inhibitory Effects of alpha-Arbutin on Melanin Synthesis in Cultured Human Melanoma Cells and a Three-Dimensional Human Skin ModelSugimoto K, Nishimura T, Nomura K, Sugimoto K, Kuriki T · Biological and Pharmaceutical Bulletin · 27(4):510-514, 2004 · DOI 10.1248/bpb.27.510 · Industry-funded — four of five authors at Ezaki Glico Co., the commercial producer of alpha-arbutin
  2. A comprehensive review of the therapeutic potential of alpha-arbutinSaeedi M, Khezri K, Seyed Zakaryaei A, Mohammadamini H · Phytotherapy Research · 35(8):4136-4154, 2021 · DOI 10.1002/ptr.7076 · Funding not determined
  3. Skin whitening agents: medicinal chemistry perspective of tyrosinase inhibitorsPillaiyar T, Manickam M, Namasivayam V · Journal of Enzyme Inhibition and Medicinal Chemistry · 32(1):403-425, 2017 · DOI 10.1080/14756366.2016.1256882 · Funding not determined
  4. The Efficacy of Topical Cosmetic Containing Alpha-Arbutin 5% and Kojic Acid 2% Compared With Triple Combination Cream for the Treatment of Melasma: A Split-Face, Evaluator-Blinded Randomized Pilot StudyTantanasrigul P, Sripha A, Chongmelaxme B · Journal of Cosmetic Dermatology · 24(1):e16562, 2025 (online 18 November 2024) · Split-face evaluator-blinded randomised PILOT study — not evidence of equivalence · DOI 10.1111/jocd.16562 · Funding not determined — Wiley returned 403, funding statement not retrieved
  5. Hydrolysis of arbutin to hydroquinone by human skin bacteria and its effect on antioxidant activityBang S-H, Han S-J, Kim D-H · Journal of Cosmetic Dermatology · 7(3):189-193, 2008 · Beta-arbutin — cited for the hydroquinone-release principle only · DOI 10.1111/j.1473-2165.2008.00387.x · Funding not determined
  6. Opinion on the safety of alpha-arbutin and beta-arbutin in cosmetic productsScientific Committee on Consumer Safety, European Commission · SCCS/1642/22 · preliminary opinion 15-16 March 2022, final opinion adopted 31 January 2023 · Institutional publication — no DOI issued · Independent — the underlying dossier was applicant-submitted
  7. Commission Regulation (EU) 2024/996 amending Regulation (EC) No 1223/2009 as regards the use of Vitamin A, Alpha-Arbutin and Arbutin and certain substances with potential endocrine disrupting properties in cosmetic productsEuropean Commission · Regulation (EU) 2024/996 of 3 April 2024 · parent act Regulation (EC) No 1223/2009, CELEX 32009R1223 · Institutional publication — no DOI issued · Independent
Product claims, registrations and availability vary by jurisdiction. Always read and follow the applicable product label.

Products

No direct product mapping. Nothing in the Vegalab range declares alpha-arbutin in its composition, so this page has no product link - the absence is deliberate, not an omission.

Last updated: